Acceleration of epithelial cell syndecan-1 shedding by anthrax hemolytic virulence factors.
BACKGROUND
It has been recently reported that major pathogens Staphylococcus aureus and Pseudomonas aeruginosa accelerate a normal process of cell surface syndecan-1 (Synd1) ectodomain shedding as a mechanism of host damage due to the production of shedding-inducing virulence factors. We tested if acceleration of Synd1 shedding takes place in vitro upon treatment of epithelial cells with B. anthracis hemolysins, as well as in vivo during anthrax infection in mice.


RESULTS
The isolated anthrax hemolytic proteins AnlB (sphingomyelinase) and AnlO (cholesterol-binding pore-forming factor), as well as ClnA (B. cereus homolog of B. anthracis phosphatidyl choline-preferring phospholipase C) cause accelerated shedding of Synd1 and E-cadherin from epithelial cells and compromise epithelial barrier integrity within a few hours. In comparison with hemolysins in a similar range of concentrations, anthrax lethal toxin (LT) also accelerates shedding albeit at slower rate. Individual components of LT, lethal factor and protective antigen are inactive with regard to shedding. Inhibition experiments favor a hypothesis that activities of tested bacterial shedding inducers converge on the stimulation of cytoplasmic tyrosine kinases of the Syk family, ultimately leading to activation of cellular sheddase. Both LT and AnlO modulate ERK1/2 and p38 MAPK signaling pathways, while JNK pathway seems to be irrelevant to accelerated shedding. Accelerated shedding of Synd1 also takes place in DBA/2 mice challenged with Bacillus anthracis (Sterne) spores. Elevated levels of shed ectodomain are readily detectable in circulation after 24 h.


CONCLUSIONS
The concerted acceleration of shedding by several virulence factors could represent a new pathogenic mechanism contributing to disruption of epithelial or endothelial integrity, hemorrhage, edema and abnormal cell signaling during anthrax infection.
Popova
Taissia G
TG
National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, VA 20110, USA. tpopova@gmu.edu
Millis
Bryan
B
Bradburne
Chris
C
Nazarenko
Svetlana
S
Bailey
Charles
C
Chandhoke
Vikas
V
Popov
Serguei G
SG
D000818:Animals; D000942:Antigens, Bacterial / Q000378:metabolism; D001408:Bacillus anthracis / Q000378:metabolism*; D001427:Bacterial Toxins / Q000378:metabolism; D015820:Cadherins / Q000378:metabolism; D002460:Cell Line; D004847:Epithelial Cells / Q000378:metabolism* / Q000382:microbiology*; D006460:Hemolysin Proteins / Q000378:metabolism; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D051379:Mice; D008811:Mice, Inbred DBA; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism; D053668:Syndecan-1 / Q000378:metabolism*; D010738:Type C Phospholipases / Q000378:metabolism; D037521:Virulence Factors / Q000378:metabolism*
D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D015820:Cadherins; D006460:Hemolysin Proteins; D053668:Syndecan-1; D037521:Virulence Factors; C030325:anthrax toxin; D007770:L-Lactate Dehydrogenase; D010738:Type C Phospholipases; D013108:Sphingomyelin Phosphodiesterase; C105598:phosphatidylcholine-specific phospholipase C